Quick Answer
Syra Health Corp reported Diluted EPS of $0.08 per share (loss) for fiscal year 2025.
Syra Health Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.08 | +84.0% |
| 2024 | -$0.50 | +16.7% |
| 2023 | -$0.60 | +14.3% |
| 2022 | -$0.70 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.02 | +66.7% | -100.0% |
| June 30, 2025 | -$0.01 | +95.2% | +75.0% |
| March 31, 2025 | -$0.04 | +81.8% | +33.3% |
| September 30, 2024 | -$0.06 | +25.0% | +71.4% |
| June 30, 2024 | -$0.21 | -16.7% | +4.5% |
| March 31, 2024 | -$0.22 | -22.2% | -175.0% |
| September 30, 2023 | -$0.08 | +11.1% | +55.6% |
| June 30, 2023 | -$0.18 | — | +0.0% |
- Syra Health Corp showed an increase of +84.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Syra Health Corp’s diluted eps has grown by 88.6% (from $0.70 per share (loss) to $0.08 per share (loss)).
- The most recent figure is from Syra Health Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: